These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A new core promoter mutation and premature stop codon in the S gene in HBV strains from Iranian patients with cirrhosis. Veazjalali M, Norder H, Magnius L, Jazayeri SM, Alavian SM, Mokhtari-Azad T. J Viral Hepat; 2009 Apr; 16(4):259-64. PubMed ID: 19222745 [Abstract] [Full Text] [Related]
25. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. Mu SC, Lin YM, Jow GM, Chen BF. J Hepatol; 2009 Feb; 50(2):264-72. PubMed ID: 19070923 [Abstract] [Full Text] [Related]
26. [A study in the Guizhou area on pre-S region mutations of hepatitis B virus]. Wang M, Ding JJ, Liu YH. Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):98-102. PubMed ID: 17362632 [Abstract] [Full Text] [Related]
27. Molecular epidemiological study of hepatitis B virus among migrant workers from Cambodia, Laos, and Myanmar to Thailand. Sa-Nguanmoo P, Tangkijvanich P, Thawornsuk N, Vichaiwattana P, Prianantathavorn K, Theamboonlers A, Tanaka Y, Poovorawan Y. J Med Virol; 2010 Aug; 82(8):1341-9. PubMed ID: 20572086 [Abstract] [Full Text] [Related]
28. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection? Vitale F, Tramuto F, Orlando A, Vizzini G, Meli V, Cerame G, Mazzucco W, Virdone R, Palazzo U, Villafrate MR, Tagger A, Romano N. J Med Virol; 2008 Apr; 80(4):577-82. PubMed ID: 18297707 [Abstract] [Full Text] [Related]
29. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, Squadrito G, Levrero M, Raimondo G. Hepatology; 2007 Feb; 45(2):277-85. PubMed ID: 17256766 [Abstract] [Full Text] [Related]
30. Molecular evolutionary analysis and mutational pattern of full-length genomes of hepatitis B virus isolated from Belgian patients with different clinical manifestations. Pourkarim MR, Amini-Bavil-Olyaee S, Verbeeck J, Lemey P, Zeller M, Rahman M, Maes P, Nevens F, Van Ranst M. J Med Virol; 2010 Mar; 82(3):379-89. PubMed ID: 20087936 [Abstract] [Full Text] [Related]
31. Molecular characterization of hepatitis B virus (HBV) isolates, including identification of a novel recombinant, in patients with acute HBV infection attending an Irish hospital. Laoi BN, Crowley B. J Med Virol; 2008 Sep; 80(9):1554-64. PubMed ID: 18649329 [Abstract] [Full Text] [Related]
34. Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Jeantet D, Chemin I, Mandrand B, Zoulim F, Trepo C, Kay A. Hepatology; 2002 May; 35(5):1215-24. PubMed ID: 11981772 [Abstract] [Full Text] [Related]
38. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI. J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397 [Abstract] [Full Text] [Related]
39. Prevalence of occult hepatitis B virus infection in a general adult population in Korea. Song EY, Yun YM, Park MH, Seo DH. Intervirology; 2009 Mar; 52(2):57-62. PubMed ID: 19401629 [Abstract] [Full Text] [Related]
40. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study. Chen CH, Changchien CS, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN. J Infect Dis; 2008 Dec 01; 198(11):1634-42. PubMed ID: 18939932 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]